(Q51552560)

6 April 2018

title

Diagnosis of Burkitt lymphoma using an algorithmic approach--applicable in both resource-poor and resource-rich countries. (English)

1 reference

6 April 2018

0 references

15

1 reference

6 April 2018

Maria R. Ambrosio

Maria R Ambrosio

6

0 references

Stefano Lazzi

Stefano Lazzi

3

0 references

Kikkeri N Naresh

Kikkeri N Naresh

1

0 references

Lorenzo Leoncini

Lorenzo Leoncini

20

0 references

Martine Raphael

18

Martine Raphael

1 reference

6 April 2018

Valeria Calbi

11

Valeria Calbi

1 reference

6 April 2018

Emily Rogena

13

Emily Rogena

1 reference

6 April 2018

Patricia Rince

4

Patricia Rince

1 reference

6 April 2018

Bessie Byakika

14

Bessie Byakika

1 reference

6 April 2018

Emma Moshi

16

Emma Moshi

1 reference

6 April 2018

Ian Magrath

19

Ian Magrath

1 reference

6 April 2018

Monica Onorati

5

Monica Onorati

1 reference

6 April 2018

Martin D Ogwang

12

Martin Ogwang

1 reference

6 April 2018

author name string

Hazem A H Ibrahim

2

1 reference

6 April 2018

Chrystèle Bilhou-Nabera

7

1 reference

6 April 2018

Furrat Amen

8

1 reference

6 April 2018

Alistair Reid

9

1 reference

6 April 2018

Michael Mawanda

10

1 reference

6 April 2018

Amos Mwakigonja

17

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 July 2011

1 reference

6 April 2018

British Journal of Haematology

published in

1 reference

6 April 2018

volume

154

1 reference

6 April 2018

issue

6

1 reference

6 April 2018

page(s)

770-776

1 reference

6 April 2018

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

Molecular diagnosis of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

RETRACTED: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08771.X

10.1111/J.1365-2141.2011.08771.X

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018